Cara Therapeutics (NASDAQ:CARA) Coverage Initiated at StockNews.com
Research analysts at StockNews.com started coverage on shares of Cara Therapeutics (NASDAQ:CARA – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Cara Therapeutics Price Performance The firm has a 50-day moving average of $15.19 and a 200-day moving […]
Research analysts at StockNews.com started coverage on shares of Cara Therapeutics (NASDAQ:CARA – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Cara Therapeutics Price Performance The firm has a 50-day moving average of $15.19 and a 200-day moving […]
